{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT02354339: Not Applicable Interventional Completed Metabolic Syndrome X
(2015)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT03418779: Phase 2/Phase 3 Interventional Active, not recruiting IgA Nephropathy at High Risk of Developing ESRD
(2019)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT02107469: Not Applicable Interventional Completed Diabetic Polyneuropathy
(2014)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT03337789: Not Applicable Interventional Completed Healthy Adults With Subjective Sleep Complaints
(2016)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT04542876: Not Applicable Interventional Completed Covid19
(2020)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT02189083: Phase 3 Interventional Completed Leiomyoma
(2014)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT01403571: Phase 2 Interventional Completed Diabetes Mellitus
(2009)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT04048616: Not Applicable Interventional Completed Age-Related Sarcopenia
(2019)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT01127126: Phase 2 Interventional Completed Overactive Bladder
(2010)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT00671138: Phase 2 Interventional Completed Celiac Disease
(2007)
Source URL:
Class:
STRUCTURALLY DIVERSE